Incidence, clinical features, and risk factors of fluoroquinolone-induced acute liver injury: a case-control study
Hong-Yi Yang, Dai-Hong Guo, Wang-Ping Jia, Man Zhu, Yuan-Jie Xu, Xiao-Yu Wang Department of Pharmaceutical Care, General Hospital of People’s Liberation Army, Beijing 100853, China Background: Fluoroquinolone-related hepatotoxicity is rare but serious and is attracting increasing attenti...
Main Authors: | Yang HY, Guo DH, Jia WP, Zhu M, Xu YJ, Wang XY |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-03-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/incidence-clinical-features-and-risk-factors-of-fluoroquinolone-induce-peer-reviewed-article-TCRM |
Similar Items
-
Comparison of Different Liver Test Thresholds for Drug-Induced Liver Injury: Updated RUCAM versus Other Methods
by: Hongyi Yang, et al.
Published: (2019-07-01) -
Drug-induced liver injury in association with antipsychotics
by: R. Zeiss, et al.
Published: (2022-06-01) -
Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacin
by: N. V. Molchan, et al.
Published: (2019-06-01) -
Fluoroquinolone-associated suspected tendonitis and tendon rupture: A pharmacovigilance analysis from 2016 to 2021 based on the FAERS database
by: Yamin Shu, et al.
Published: (2022-09-01) -
Liver Injury with Nintedanib: A Pharmacovigilance–Pharmacokinetic Appraisal
by: Emanuel Raschi, et al.
Published: (2022-05-01)